title: Re: A Double-Blind, Placebo Controlled, Randomized Phase 1 Cross-Over Study with ALLN-177, an Orally Administered Oxalate Degrading Enzyme.
authors.forename: Dean G
authors.initials: DG
authors.lastname: Assimos
mesh_terms: D000284:Administration, Oral; D018592:Cross-Over Studies; D004311:Double-Blind Method; D010070:Oxalates
chemical_list: D010070:Oxalates